Theranosis Life Sciences has raised an undisclosed amount from Mumbai Angels Network.
By Team ABLE
Diagnostics startup Theranosis Life Sciences Pvt. Ltd, which focuses on the oncology space, has raised an undisclosed amount from Mumbai Angels Network. The Hyderabad-based startup, which was founded by Shibichakravarthy Kannan and Vennila Dharman in 2016, deals with non-invasive diagnostics for cancer patients.
The company has developed a chip device which detects circulating tumor cells from a blood sample of a cancer patient. This procedure, called liquid biopsy, is a less invasive method and diminishes severe adverse effects triggered by chemotherapy, the statement said. Another beneficial outcome is that it monitors treatment responses in real time, it added.
Chief Executive Officer and Managing Director of Mumbai Angels Network, Nandini Mansinghka, has said in a statement that the network’s investment in Theranosis highlighted its focus on niche opportunities in the healthcare and health-tech space.Source: VC Circle